Catherine Skari

TIF Newsletter – July 2021

Read More »

Hemoglobin Disorders In Europe: A Systematic Effort Of Identifying And Addressing Unmet Needs And Challenges By TIF

The recent population movement has led to a steady increase of carriers and patients with haemoglobin disorders, namely thalassaemia and…

Read More »

WORLD BLOOD DONOR DAY 2022 | Donating Blood Is An Act Of Solidarity

Read More »

Bluebird Bio Resumes Marketing Of Gene Therapy Zynteglo For β-Thalassaemia In Europe

The European Medicines Agency (EMA)’s safety committee (PRAC) has concluded that there is no evidence Zynteglo causes a blood cancer…

Read More »

Live Webinar on Thalassemia: Advances in 2021 with Dr M.D. Cappellini

The past decade has witnessed path-breaking advances with regard to novel therapeutic approaches of thalassaemia and, most significantly, phenomenal developments…

Read More »

Clinical Trials Update: The June 2021 Edition

TIF provides you with comprehensive and up-to-date information on developing drugs and therapies for thalassaemia and sickle cell disease (SCD)…

Read More »

NTS’s President & Vice President Meet With Iraqi Government Officials To Discuss Thalassaemia Prevention National Programme

In response to the invitation of the Prime Minister’s Advisors Authority to Mr. Thaer Ibrahim Al-Taei, President of the Thalassemia…

Read More »

The June Update: TIF’s Guide On COVID-19 Vaccinations & Therapeutic Drugs

As vaccination rates are slowing in the US and Europe, the spread of the Delta coronavirus variants causes growing concerns…

Read More »

It’s Here: The 4th Edition Of TIF Guidelines For The Management of TDT

TIF, its Board of Directors, and its International Scientific Advisory Board proudly present the 4th Edition of the Federation’s most…

Read More »

Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th edition – Version 2.0)

Maria Domenica Cappellini, MD FACP Farmakis Dimitrios, MD, PhD, FESC Porter John, MBBS, MD, MPH, FRCP Ali T. Taher, MD,…

Read More »